1121 related articles for article (PubMed ID: 18329476)
1. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
2. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
Lischke R; Simonek J; Davidová R; Schützner J; Stolz AJ; Vojácek J; Burkert J; Pafko P
Transplant Proc; 2007; 39(1):205-12. PubMed ID: 17275507
[TBL] [Abstract][Full Text] [Related]
3. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
[TBL] [Abstract][Full Text] [Related]
4. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
[TBL] [Abstract][Full Text] [Related]
5. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
Kobashigawa J; David K; Morris J; Chu AH; Steffen BJ; Gotz VP; Gordon RD
Transplant Proc; 2005 Mar; 37(2):1333-9. PubMed ID: 15848713
[TBL] [Abstract][Full Text] [Related]
6. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-thymocyte globulin and daclizumab.
Burton CM; Andersen CB; Jensen AS; Iversen M; Milman N; Boesgaard S; Arendrup H; Eliasen K; Carlsen J
J Heart Lung Transplant; 2006 Jun; 25(6):638-47. PubMed ID: 16730569
[TBL] [Abstract][Full Text] [Related]
7. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
8. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
Stratta RJ; Alloway RR; Lo A; Hodge E
Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
[TBL] [Abstract][Full Text] [Related]
9. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab.
Brock MV; Borja MC; Ferber L; Orens JB; Anzcek RA; Krishnan J; Yang SC; Conte JV
J Heart Lung Transplant; 2001 Dec; 20(12):1282-90. PubMed ID: 11744411
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of lung transplantation for cystic fibrosis--Danish results.
Bech B; Pressler T; Iversen M; Carlsen J; Milman N; Eliasen K; Perko M; Arendrup H
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1180-6. PubMed ID: 15541981
[TBL] [Abstract][Full Text] [Related]
11. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
Date H; Lynch JP; Sundaresan S; Patterson GA; Trulock EP
J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
[TBL] [Abstract][Full Text] [Related]
13. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after pulmonary retransplantation.
Strueber M; Fischer S; Gottlieb J; Simon AR; Goerler H; Gohrbandt B; Welte T; Haverich A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):407-12. PubMed ID: 16872970
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation as the first choice in emphysema.
Delgado M; Borro JM; De La Torre MM; Fernández R; González D; Paradela M; García JA; Fieira E; Rama P
Transplant Proc; 2009; 41(6):2207-9. PubMed ID: 19715874
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.
Mullen JC; Oreopoulos A; Lien DC; Bentley MJ; Modry DL; Stewart K; Winton TL; Jackson K; Doucette K; Preiksaitis J; Halloran PF
J Heart Lung Transplant; 2007 May; 26(5):504-10. PubMed ID: 17449421
[TBL] [Abstract][Full Text] [Related]
19. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB
J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases.
Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
